Barrow, Hanley, Mewhinney & Strauss’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.66K Buy
49
+4
+9% +$288 ﹤0.01% 315
2026
Q1
$3.21K Hold
45
– – ﹤0.01% 303
2025
Q4
$2.66K Buy
+45
New +$2.44K ﹤0.01% 306
2024
Q2
– Sell
-236
Closed -$11.3K – 327
2024
Q1
$11.3K Sell
236
-4
-2% -$180 ﹤0.01% 192
2023
Q4
$11.3K Buy
240
+103
+75% +$4.28K ﹤0.01% 181
2023
Q3
$6.52K Hold
137
– – ﹤0.01% 214
2023
Q2
$7.97K Hold
137
– – ﹤0.01% 199
2023
Q1
$9.8K Hold
137
– – ﹤0.01% 180
2022
Q4
$9.65K Sell
137
-11
-7% -$775 ﹤0.01% 173
2022
Q3
$9K Sell
148
-7
-5% -$470 ﹤0.01% 164
2022
Q2
$10K Sell
155
-45
-23% -$2.93K ﹤0.01% 174
2022
Q1
$13K Buy
+200
New +$13.4K ﹤0.01% 164
2021
Q4
– Sell
-1,164
Closed -$83K – 356
2021
Q3
$83K Hold
1,164
– – ﹤0.01% 222
2021
Q2
$95K Sell
1,164
-717
-38% -$57.7K ﹤0.01% 219
2021
Q1
$142K Sell
1,881
-407
-18% -$29.6K ﹤0.01% 209
2020
Q4
$173K Sell
2,288
-3,130
-58% -$204K ﹤0.01% 168
2020
Q3
$267K Sell
5,418
-18,878
-78% -$1.07M ﹤0.01% 179
2020
Q2
$1.28M Buy
24,296
+7,312
+43% +$347K 0.01% 155
2020
Q1
$598K Buy
16,984
+7,759
+84% +$453K ﹤0.01% 201
2019
Q4
$806K Buy
+9,225
New +$807K ﹤0.01% 246

Other funds holding NGVT

Barrow, Hanley, Mewhinney & Strauss's NGVT Position: Q2 2026 in Review

Barrow, Hanley, Mewhinney & Strauss increased its Ingevity (NGVT) stake by 8.9% in Q2 2026, buying an estimated $288 and bringing the position to 49 shares worth $3.66K. The position accounts for ﹤0.01% of the portfolio, ranked #315.

Barrow, Hanley, Mewhinney & Strauss first reported a position in NGVT in Q4 2019 and has held it in 20 quarters since. The position peaked at $1.28M in Q2 2020. 316 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

  • Barrow, Hanley, Mewhinney & Strauss held 49 shares of Ingevity worth $3.66K as of Q2 2026.
  • Barrow, Hanley, Mewhinney & Strauss bought 4 Ingevity shares in Q2 2026, an estimated $288.
  • Ingevity made up ﹤0.01% of Barrow, Hanley, Mewhinney & Strauss's portfolio in Q2 2026, its #315 holding.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in Ingevity in Q4 2019 and has held it in 20 quarters since.
  • Barrow, Hanley, Mewhinney & Strauss's Ingevity position peaked at $1.28M in Q2 2020.
  • 316 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2026, filed 12 Aug 2026.